Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1869056293;56294;56295 chr2:178599833;178599832;178599831chr2:179464560;179464559;179464558
N2AB1704951370;51371;51372 chr2:178599833;178599832;178599831chr2:179464560;179464559;179464558
N2A1612248589;48590;48591 chr2:178599833;178599832;178599831chr2:179464560;179464559;179464558
N2B962529098;29099;29100 chr2:178599833;178599832;178599831chr2:179464560;179464559;179464558
Novex-1975029473;29474;29475 chr2:178599833;178599832;178599831chr2:179464560;179464559;179464558
Novex-2981729674;29675;29676 chr2:178599833;178599832;178599831chr2:179464560;179464559;179464558
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTA
  • RefSeq wild type template codon: GAT
  • Domain: Ig-116
  • Domain position: 3
  • Structural Position: 3
  • Q(SASA): 0.5409
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/I None None 0.999 N 0.517 0.355 0.490352026379 gnomAD-4.0.0 1.65436E-06 None None None None I None 0 0 None 0 0 None 0 0 2.94301E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.8386 likely_pathogenic 0.8072 pathogenic -2.382 Highly Destabilizing 0.999 D 0.691 prob.neutral None None None None I
L/C 0.8255 likely_pathogenic 0.7823 pathogenic -1.447 Destabilizing 1.0 D 0.664 neutral None None None None I
L/D 0.995 likely_pathogenic 0.9934 pathogenic -2.434 Highly Destabilizing 1.0 D 0.72 prob.delet. None None None None I
L/E 0.9758 likely_pathogenic 0.9704 pathogenic -2.343 Highly Destabilizing 1.0 D 0.741 deleterious None None None None I
L/F 0.6126 likely_pathogenic 0.4931 ambiguous -1.545 Destabilizing 1.0 D 0.691 prob.neutral None None None None I
L/G 0.9558 likely_pathogenic 0.9409 pathogenic -2.81 Highly Destabilizing 1.0 D 0.739 prob.delet. None None None None I
L/H 0.9646 likely_pathogenic 0.9517 pathogenic -2.184 Highly Destabilizing 1.0 D 0.717 prob.delet. None None None None I
L/I 0.1886 likely_benign 0.1721 benign -1.201 Destabilizing 0.999 D 0.517 neutral N 0.500944339 None None I
L/K 0.9645 likely_pathogenic 0.9592 pathogenic -1.951 Destabilizing 1.0 D 0.711 prob.delet. None None None None I
L/M 0.185 likely_benign 0.1699 benign -0.881 Destabilizing 1.0 D 0.662 neutral None None None None I
L/N 0.974 likely_pathogenic 0.9661 pathogenic -1.869 Destabilizing 1.0 D 0.723 prob.delet. None None None None I
L/P 0.97 likely_pathogenic 0.9556 pathogenic -1.571 Destabilizing 1.0 D 0.724 prob.delet. N 0.51516443 None None I
L/Q 0.923 likely_pathogenic 0.9018 pathogenic -1.949 Destabilizing 1.0 D 0.707 prob.neutral N 0.520647607 None None I
L/R 0.951 likely_pathogenic 0.937 pathogenic -1.384 Destabilizing 1.0 D 0.725 prob.delet. N 0.494971947 None None I
L/S 0.9457 likely_pathogenic 0.9254 pathogenic -2.466 Highly Destabilizing 1.0 D 0.72 prob.delet. None None None None I
L/T 0.7346 likely_pathogenic 0.7042 pathogenic -2.26 Highly Destabilizing 1.0 D 0.731 prob.delet. None None None None I
L/V 0.1958 likely_benign 0.1743 benign -1.571 Destabilizing 0.999 D 0.565 neutral N 0.497018599 None None I
L/W 0.9276 likely_pathogenic 0.8893 pathogenic -1.804 Destabilizing 1.0 D 0.706 prob.neutral None None None None I
L/Y 0.9505 likely_pathogenic 0.9319 pathogenic -1.599 Destabilizing 1.0 D 0.716 prob.delet. None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.